Literature DB >> 23974958

Use of a fundamental approach to spray-drying formulation design to facilitate the development of multi-component dry powder aerosols for respiratory drug delivery.

Susan Hoe1, James W Ivey, Mohammed A Boraey, Abouzar Shamsaddini-Shahrbabak, Emadeddin Javaheri, Sadaf Matinkhoo, Warren H Finlay, Reinhard Vehring.   

Abstract

PURPOSE: A fundamental approach incorporating current theoretical models into aerosol formulation design potentially reduces experimental work for complex formulations. A D-amino acid mixture containing D-Leucine (D-Leu), D-Methionine, D-Tryptophan, and D-Tyrosine was selected as a model formulation for this approach.
METHODS: Formulation design targets were set, with the aim of producing a highly dispersible D-amino acid aerosol. Particle formation theory and a spray dryer process model were applied with boundary conditions to the design targets, resulting in a priori predictions of particle morphology and necessary spray dryer process parameters. Two formulations containing 60% w/w trehalose, 30% w/w D-Leu, and 10% w/w remaining D-amino acids were manufactured.
RESULTS: The design targets were met. The formulations had rugose and hollow particles, caused by deformation of a crystalline D-Leu shell while trehalose remained amorphous, as predicted by particle formation theory. D-Leu acts as a dispersibility enhancer, ensuring that both formulations: 1) delivered over 40% of the loaded dose into the in vitro lung region, and 2) achieved desired values of lung airway surface liquid concentrations based on lung deposition simulations.
CONCLUSIONS: Theoretical models were applied to successfully achieve complex formulations with design challenges a priori. No further iterations to the design process were required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974958     DOI: 10.1007/s11095-013-1174-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

1.  Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern?

Authors:  Abdul Ashish; Matthew Shaw; C Winstanley; Martin J Ledson; Martin J Walshaw
Journal:  J Cyst Fibros       Date:  2011-12-05       Impact factor: 5.482

2.  Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.

Authors:  R P Aquino; L Prota; G Auriemma; A Santoro; T Mencherini; G Colombo; P Russo
Journal:  Int J Pharm       Date:  2012-01-23       Impact factor: 5.875

3.  Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis.

Authors:  Clement L Ren; Michael W Konstan; Ashley Yegin; Lawrence Rasouliyan; Benjamin Trzaskoma; Wayne J Morgan; Warren Regelmann
Journal:  J Cyst Fibros       Date:  2012-03-23       Impact factor: 5.482

4.  Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.

Authors:  Pholawat Tingpej; Mark Elkins; Barbara Rose; Honghua Hu; Carmel Moriarty; Jim Manos; Belinda Barras; Peter Bye; Colin Harbour
Journal:  Respirology       Date:  2010-06-21       Impact factor: 6.424

5.  Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.

Authors:  Gerard McCaughey; Matt McKevitt; J Stuart Elborn; Michael M Tunney
Journal:  J Cyst Fibros       Date:  2011-12-03       Impact factor: 5.482

6.  A Model-Based Methodology for Spray-Drying Process Development.

Authors:  Dan E Dobry; Dana M Settell; John M Baumann; Rod J Ray; Lisa J Graham; Ron A Beyerinck
Journal:  J Pharm Innov       Date:  2009-07-25       Impact factor: 2.750

7.  Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.

Authors:  Yoen-Ju Son; P Worth Longest; Michael Hindle
Journal:  Int J Pharm       Date:  2013-01-10       Impact factor: 5.875

8.  Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.

Authors:  V Naini; P R Byron; E M Phillips
Journal:  Drug Dev Ind Pharm       Date:  1998-10       Impact factor: 3.225

9.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

Review 10.  Emerging knowledge of regulatory roles of D-amino acids in bacteria.

Authors:  Felipe Cava; Hubert Lam; Miguel A de Pedro; Matthew K Waldor
Journal:  Cell Mol Life Sci       Date:  2010-12-14       Impact factor: 9.261

View more
  11 in total

1.  A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.

Authors:  S Focaroli; P T Mah; J E Hastedt; I Gitlin; S Oscarson; J V Fahy; A M Healy
Journal:  Int J Pharm       Date:  2019-03-05       Impact factor: 5.875

2.  Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.

Authors:  Frantiescoli Dimer; Cristiane de Souza Carvalho-Wodarz; Jörg Haupenthal; Rolf Hartmann; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2015-06-26       Impact factor: 4.200

3.  Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.

Authors:  Worth Longest; Amr Hassan; Dale Farkas; Michael Hindle
Journal:  Pharm Res       Date:  2022-02-11       Impact factor: 4.200

4.  Spray Dried Rugose Lipid Particle Platform for Respiratory Drug Delivery.

Authors:  Hui Wang; Mani Ordoubadi; Patrick Connaughton; Kellisa Lachacz; Nicholas Carrigy; Scott Tavernini; Andrew R Martin; Warren H Finlay; David Lechuga-Ballesteros; Reinhard Vehring
Journal:  Pharm Res       Date:  2022-04-01       Impact factor: 4.200

5.  Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.

Authors:  Hiroko Otake; Tomoyuki Okuda; Daiki Hira; Haruyoshi Kojima; Yasuhiro Shimada; Hirozazu Okamoto
Journal:  Pharm Res       Date:  2015-12-07       Impact factor: 4.200

6.  Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate.

Authors:  Mellissa Gomez; Joseph McCollum; Hui Wang; Mani Ordoubadi; Chester Jar; Nicholas B Carrigy; David Barona; Isobel Tetreau; Michelle Archer; Alana Gerhardt; Chris Press; Christopher B Fox; Ryan M Kramer; Reinhard Vehring
Journal:  Int J Pharm       Date:  2020-12-02       Impact factor: 5.875

7.  Computational Fluid Dynamics (CFD) Simulations of Spray Drying: Linking Drying Parameters with Experimental Aerosolization Performance.

Authors:  P Worth Longest; Dale Farkas; Amr Hassan; Michael Hindle
Journal:  Pharm Res       Date:  2020-05-21       Impact factor: 4.200

8.  Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying.

Authors:  Mellissa Gomez; Michelle Archer; David Barona; Hui Wang; Mani Ordoubadi; Shabab Bin Karim; Nicholas B Carrigy; Zheng Wang; Joseph McCollum; Chris Press; Alana Gerhardt; Christopher B Fox; Ryan M Kramer; Reinhard Vehring
Journal:  Eur J Pharm Biopharm       Date:  2021-03-19       Impact factor: 5.589

9.  Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders.

Authors:  Rita Patrizia Aquino; Mariateresa Stigliani; Pasquale Del Gaudio; Teresa Mencherini; Francesca Sansone; Paola Russo
Journal:  ScientificWorldJournal       Date:  2014-12-16

10.  The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant.

Authors:  Eleonora Maretti; Cecilia Rustichelli; Magdalena Lassinantti Gualtieri; Luca Costantino; Cristina Siligardi; Paola Miselli; Francesca Buttini; Monica Montecchi; Eliana Leo; Eleonora Truzzi; Valentina Iannuccelli
Journal:  Pharmaceutics       Date:  2019-10-01       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.